Cipla (CIPLA) — Announcement

Cipla disclosed a revised tax demand of INR 559.18 crores for assessment years 2015-16 to 2022-23 after a rectification order reduced the liability from INR 773.44 crores, reflecting a significant decrease in tax exposure.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does this announcement affect Cipla Limited's outlook?" "What did Cipla Limited announce on 14 January 2025?" "Is this positive or negative for CIPLA?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 14 January 2025

HAVELLS Havells India Limited Corporate Action APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results KOTAKBANK Kotak Mahindra Bank Limited Financial Results AXISBANK Axis Bank Limited Corporate Action SIEMENS Siemens Limited Annual Report CONCOR Container Corporation of India Limited deviation variation

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.